NCPSSM President and House Members Team-Up to Tout New Prescription Drug Pricing Measures

NCPSSM President and CEO Max Richtman joined two Pennsylvania congressmen in announcing that seniors will benefit from the just-enacted Inflation Reduction Act. Richtman appeared last week at Circle Pharmacy in Philadelphia with representatives Brendan Boyle (D-PA) and Dwight Evans (D-PA).

House Passes Historic Prescription Drug Pricing Legislation

The U.S. House today passed historic legislation to bring down prescription drug prices for tens of millions of American seniors. The Inflation Reduction Act, which the Senate passed last weekend after intense negotiations between Senate Majority Leader Chuck Schumer and West Virginia Senator Joe Manchin, now goes to President Biden's desk for signature.  It is the most sweeping health care legislation since the enactment of the Affordable Care Act in 2010.

The Part D Prescription Drug Bait and Switch

Medicare Part D prescription drug beneficiaries can be in for a rude surprise after they sign up for coverage.   In an article this week in Kaiser Health News, Susan Jaffe writes that the price of a drug may jump within a month of a patient enrolling in the Part D drug plan

House Passage of Build Back Better is Something For Seniors To Be Thankful For

The House of Representatives passed President Biden’s landmark Build Back Better plan this morning --- a victory achieved by Democrats to benefit American seniors.  The House-enacted legislation represents the biggest expansion of the social safety net for older Americans and their families in five decades.

Dems Should Unite Around Medicare Expansion, RX Drug Price Negotiation

We and other seniors' advocates cheered President Biden's Build Back Better plan, which called for adding dental, vision, and hearing coverage to Medicare. That plan is having a difficult birth in Congress, as moderate and Progressive Democrats wrangle over the plan's size and scope.
2021-10-15T14:34:18-04:00October 15th, 2021|Categories: Congress, Medicare, Medicare Drug Coverage and Costs, Polls, Prescription Drug Prices, President Biden|

Holdout House Dems Should Side with the People, Not Big Pharma

Nearly 90% of the American public wants Medicare to be able to negotiate drug prices with Big Pharma – including a majority of Republicans. Unfortunately, the will of the people is being thwarted not only by Republicans in Congress, who refuse to support Medicare price negotiation, but holdout ‘moderate’ Democrats.
2021-09-17T15:02:03-04:00September 17th, 2021|Categories: Democrats, Medicare, Medicare Drug Coverage and Costs, Polls, President Biden, Republicans|
Go to Top